Target intelligence / Profile preview

RAB9A, member RAS oncogene family pseudogene 4 (RAB9AP4)

Target: RAB9AP4
Molecular classification: Other (Pseudogene)

Overview

RAB9AP4 (RAB9A, member RAS oncogene family pseudogene 4) is classified as a pseudogene in the human genome, sharing homology with the protein-coding RAB9A gene but lacking functional protein expression. RAB9AP4 does not encode any active protein, does not have described biological or disease roles, and should not be confused with the functional RAB9A protein or considered a drug target. The naming similarity to RAB9A often leads to confusion, but therapeutic interest and research focus on RAB9A, not RAB9AP4[1].

Other names: RAB9AP4Pseudogene of RAB9A

Beyond the preview

Go deeper on RAB9A, member RAS oncogene family pseudogene 4 (RAB9AP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAB9A, member RAS oncogene family pseudogene 4 (RAB9AP4).

Explore the full profile